<?xml version="1.0" encoding="UTF-8"?>
<p>Although effective vaccines against myxomatosis have been available for some time the disease persists. “Heterologous” vaccines based on the rabbit (Shope) fibroma virus have been used since 1955 and “homologous” vaccines (e.g., the 
 <italic>SG 33</italic> strain [
 <xref rid="B17-animals-09-00780" ref-type="bibr">17</xref>], 
 <italic>León 162</italic>, and 
 <italic>VMI 30</italic> strains) since the 1980s with different adjuvants, and administration routes: subcutaneous or intradermic [
 <xref rid="B18-animals-09-00780" ref-type="bibr">18</xref>,
 <xref rid="B19-animals-09-00780" ref-type="bibr">19</xref>,
 <xref rid="B20-animals-09-00780" ref-type="bibr">20</xref>]. 
</p>
